Evidence map›Paper›PMID 28593166›Full record

ArticleProstate international2017

Protective effect of

Jorge Arroyo-Acevedo, Oscar Herrera-Calderón, Roberto Chávez-Asmat, Andrea Anampa-Guzmán, Víctor Chumpitaz-Cerrate, Edwin Enciso-Roca

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Prostate international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Protective effect ofOncoTargets and therapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jorge Arroyo-AcevedoInstitute of Clinical Research, National University of San Marcos, Lima, Peru.
Oscar Herrera-CalderónFaculty of Pharmacy and Biochemistry, Universidad Nacional San Luis de Gonzaga, Ica, Peru.
Roberto Chávez-AsmatPharmacology Laboratory, Faculty of Medicine, National University of San Marcos, Lima, Peru.
Andrea Anampa-GuzmánFaculty of Medicine, National University of San Marcos, Lima, Peru.
Víctor Chumpitaz-CerrateFaculty of Odontology, National University of San Marcos, Lima, Peru.
Edwin Enciso-RocaFaculty of Health Sciences, Universidad Nacional San Cristobal de Huamanga, Ayacucho, Peru.
National University of San Marcos · PESaint Aloysius Gonzaga National University · PESan Cristóbal of Huamanga University · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe main objective was to evaluate the possible protective effect of MATERIALS AND

methodsProstate carcinogenesis was induced in 30 male Holtzman rats by providing cyproterone acetate, testosterone, and NMU. The tumors were monitored and hematological and biochemical parameters and frequency of micronucleated polychromatic erythrocytes were recorded. The cell line was assessed by a cytotoxicity assay.

resultsOral administration of

conclusionsConsidering its anti-inflammatory, antioxidant, and antigenotoxic effects, and important variations on biochemical and hematological parameters, including prostate-specific antigen of

Indexed as

AntigenotoxicityAnti-inflammatoryAntioxidantChuquiraga spinosaCytotoxicity

Identifiers

PMID28593166
PMCPMC5448729
OpenAlexW2579410602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.